Patrys Ltd
ASX:PAB
Patrys Ltd
Revenue
Patrys Ltd
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Patrys Ltd
ASX:PAB
|
Revenue
AU$1.7m
|
CAGR 3-Years
25%
|
CAGR 5-Years
27%
|
CAGR 10-Years
9%
|
|
Immutep Ltd
ASX:IMM
|
Revenue
AU$256.6k
|
CAGR 3-Years
-61%
|
CAGR 5-Years
-45%
|
CAGR 10-Years
-24%
|
|
Mesoblast Ltd
ASX:MSB
|
Revenue
$7.5m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
CSL Ltd
ASX:CSL
|
Revenue
$14.2B
|
CAGR 3-Years
12%
|
CAGR 5-Years
11%
|
CAGR 10-Years
10%
|
|
Clinuvel Pharmaceuticals Ltd
ASX:CUV
|
Revenue
AU$87.3m
|
CAGR 3-Years
31%
|
CAGR 5-Years
25%
|
CAGR 10-Years
42%
|
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
Revenue
AU$502.5m
|
CAGR 3-Years
359%
|
CAGR 5-Years
381%
|
CAGR 10-Years
N/A
|
See Also
What is Patrys Ltd's Revenue?
Revenue
1.7m
AUD
Based on the financial report for Dec 31, 2023, Patrys Ltd's Revenue amounts to 1.7m AUD.
What is Patrys Ltd's Revenue growth rate?
Revenue CAGR 10Y
9%
Over the last year, the Revenue growth was -52%. The average annual Revenue growth rates for Patrys Ltd have been 25% over the past three years , 27% over the past five years , and 9% over the past ten years .